Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis

Damon A Lowes, Helen F Galley

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Oxidative stress and mitochondrial dysfunction are common features in patients with sepsis and organ failure. Within mitochondria, superoxide is converted into hydrogen peroxide by MnSOD (manganese-containing superoxide dismutase), which is then detoxified by either the mGSH (mitochondrial glutathione) system, using the enzymes mGPx-1 (mitochondrial glutathione peroxidase-1), GRD (glutathione reductase) and mGSH, or the TRX-2 (thioredoxin-2) system, which uses the enzymes PRX-3 (peroxiredoxin-3) and TRX-2R (thioredoxin reductase-2) and TRX-2. In the present paper we investigated the relative contribution of these two systems, using selective inhibitors, in relation to mitochondrial dysfunction in endothelial cells cultured with LPS (lipopolysaccharide) and PepG (peptidoglycan). Specific inhibition of both the TRX-2 and mGSH systems increased the intracellular total radical production (P< 0.05) and reduced mitochondrial membrane potentials (P< 0.05). Inhibition of the TRX-2 system, but not mGSH, resulted in
lower ATP production (P< 0.001) with high metabolic activity (P< 0.001), low oxygen consumption (P< 0.001) and increased lactate production (P< 0.001) and caspase 3/7 activation (P<0.05). Collectively these results show that the TRX-2 system appears to have a more important role in preventingmitochondrial dysfunction than the mGSH system in endothelial cells under conditions that mimic a septic insult.
Original languageEnglish
Pages (from-to)123-132
Number of pages10
JournalBiochemical Journal
Volume436
Issue number1
Early online date28 Feb 2011
DOIs
Publication statusPublished - 15 May 2011

Fingerprint

Thioredoxins
Glutathione
Sepsis
Endothelial cells
Thioredoxin Reductase 2
Peroxiredoxin III
Endothelial Cells
Caspase 7
Mitochondria
Oxidative stress
Peptidoglycan
Glutathione Reductase
Mitochondrial Membrane Potential
Enzymes
Manganese
Oxygen Consumption
Superoxides
Caspase 3
Hydrogen Peroxide
Superoxide Dismutase

Keywords

  • animals
  • endothelial Cells
  • glutathione
  • glutathione Peroxidase
  • glutathione Reductase
  • humans
  • membrane potential, mitochondrial
  • mice
  • mitochondria
  • peroxiredoxin III
  • sepsis
  • thioredoxin reductase 2
  • thioredoxins

Cite this

Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. / Lowes, Damon A; Galley, Helen F.

In: Biochemical Journal, Vol. 436, No. 1, 15.05.2011, p. 123-132.

Research output: Contribution to journalArticle

@article{5939e7c46a8c4aa6bc932678f07476df,
title = "Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis",
abstract = "Oxidative stress and mitochondrial dysfunction are common features in patients with sepsis and organ failure. Within mitochondria, superoxide is converted into hydrogen peroxide by MnSOD (manganese-containing superoxide dismutase), which is then detoxified by either the mGSH (mitochondrial glutathione) system, using the enzymes mGPx-1 (mitochondrial glutathione peroxidase-1), GRD (glutathione reductase) and mGSH, or the TRX-2 (thioredoxin-2) system, which uses the enzymes PRX-3 (peroxiredoxin-3) and TRX-2R (thioredoxin reductase-2) and TRX-2. In the present paper we investigated the relative contribution of these two systems, using selective inhibitors, in relation to mitochondrial dysfunction in endothelial cells cultured with LPS (lipopolysaccharide) and PepG (peptidoglycan). Specific inhibition of both the TRX-2 and mGSH systems increased the intracellular total radical production (P< 0.05) and reduced mitochondrial membrane potentials (P< 0.05). Inhibition of the TRX-2 system, but not mGSH, resulted in lower ATP production (P< 0.001) with high metabolic activity (P< 0.001), low oxygen consumption (P< 0.001) and increased lactate production (P< 0.001) and caspase 3/7 activation (P<0.05). Collectively these results show that the TRX-2 system appears to have a more important role in preventingmitochondrial dysfunction than the mGSH system in endothelial cells under conditions that mimic a septic insult.",
keywords = "animals, endothelial Cells, glutathione, glutathione Peroxidase, glutathione Reductase, humans, membrane potential, mitochondrial, mice, mitochondria, peroxiredoxin III, sepsis, thioredoxin reductase 2, thioredoxins",
author = "Lowes, {Damon A} and Galley, {Helen F}",
year = "2011",
month = "5",
day = "15",
doi = "10.1042/BJ20102135",
language = "English",
volume = "436",
pages = "123--132",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis

AU - Lowes, Damon A

AU - Galley, Helen F

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Oxidative stress and mitochondrial dysfunction are common features in patients with sepsis and organ failure. Within mitochondria, superoxide is converted into hydrogen peroxide by MnSOD (manganese-containing superoxide dismutase), which is then detoxified by either the mGSH (mitochondrial glutathione) system, using the enzymes mGPx-1 (mitochondrial glutathione peroxidase-1), GRD (glutathione reductase) and mGSH, or the TRX-2 (thioredoxin-2) system, which uses the enzymes PRX-3 (peroxiredoxin-3) and TRX-2R (thioredoxin reductase-2) and TRX-2. In the present paper we investigated the relative contribution of these two systems, using selective inhibitors, in relation to mitochondrial dysfunction in endothelial cells cultured with LPS (lipopolysaccharide) and PepG (peptidoglycan). Specific inhibition of both the TRX-2 and mGSH systems increased the intracellular total radical production (P< 0.05) and reduced mitochondrial membrane potentials (P< 0.05). Inhibition of the TRX-2 system, but not mGSH, resulted in lower ATP production (P< 0.001) with high metabolic activity (P< 0.001), low oxygen consumption (P< 0.001) and increased lactate production (P< 0.001) and caspase 3/7 activation (P<0.05). Collectively these results show that the TRX-2 system appears to have a more important role in preventingmitochondrial dysfunction than the mGSH system in endothelial cells under conditions that mimic a septic insult.

AB - Oxidative stress and mitochondrial dysfunction are common features in patients with sepsis and organ failure. Within mitochondria, superoxide is converted into hydrogen peroxide by MnSOD (manganese-containing superoxide dismutase), which is then detoxified by either the mGSH (mitochondrial glutathione) system, using the enzymes mGPx-1 (mitochondrial glutathione peroxidase-1), GRD (glutathione reductase) and mGSH, or the TRX-2 (thioredoxin-2) system, which uses the enzymes PRX-3 (peroxiredoxin-3) and TRX-2R (thioredoxin reductase-2) and TRX-2. In the present paper we investigated the relative contribution of these two systems, using selective inhibitors, in relation to mitochondrial dysfunction in endothelial cells cultured with LPS (lipopolysaccharide) and PepG (peptidoglycan). Specific inhibition of both the TRX-2 and mGSH systems increased the intracellular total radical production (P< 0.05) and reduced mitochondrial membrane potentials (P< 0.05). Inhibition of the TRX-2 system, but not mGSH, resulted in lower ATP production (P< 0.001) with high metabolic activity (P< 0.001), low oxygen consumption (P< 0.001) and increased lactate production (P< 0.001) and caspase 3/7 activation (P<0.05). Collectively these results show that the TRX-2 system appears to have a more important role in preventingmitochondrial dysfunction than the mGSH system in endothelial cells under conditions that mimic a septic insult.

KW - animals

KW - endothelial Cells

KW - glutathione

KW - glutathione Peroxidase

KW - glutathione Reductase

KW - humans

KW - membrane potential, mitochondrial

KW - mice

KW - mitochondria

KW - peroxiredoxin III

KW - sepsis

KW - thioredoxin reductase 2

KW - thioredoxins

U2 - 10.1042/BJ20102135

DO - 10.1042/BJ20102135

M3 - Article

C2 - 21355852

VL - 436

SP - 123

EP - 132

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -